GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » SMO Clinplus Co Ltd (SZSE:301257) » Definitions » EV-to-FCF

SMO Clinplus Co (SZSE:301257) EV-to-FCF : 20.33 (As of Jun. 06, 2024)


View and export this data going back to 2022. Start your Free Trial

What is SMO Clinplus Co EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, SMO Clinplus Co's Enterprise Value is ¥1,553.5 Mil. SMO Clinplus Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 was ¥76.4 Mil. Therefore, SMO Clinplus Co's EV-to-FCF for today is 20.33.

The historical rank and industry rank for SMO Clinplus Co's EV-to-FCF or its related term are showing as below:

SZSE:301257' s EV-to-FCF Range Over the Past 10 Years
Min: -118.85   Med: 35.93   Max: 201.78
Current: 21.12

During the past 7 years, the highest EV-to-FCF of SMO Clinplus Co was 201.78. The lowest was -118.85. And the median was 35.93.

SZSE:301257's EV-to-FCF is ranked better than
56.04% of 91 companies
in the Medical Diagnostics & Research industry
Industry Median: 25.22 vs SZSE:301257: 21.12

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-06-06), SMO Clinplus Co's stock price is ¥29.32. SMO Clinplus Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥1.684. Therefore, SMO Clinplus Co's PE Ratio for today is 17.41.


SMO Clinplus Co EV-to-FCF Historical Data

The historical data trend for SMO Clinplus Co's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SMO Clinplus Co EV-to-FCF Chart

SMO Clinplus Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial - - - 65.03 28.49

SMO Clinplus Co Quarterly Data
Dec17 Dec18 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 37.38 17.51 25.34 28.49 27.78

Competitive Comparison of SMO Clinplus Co's EV-to-FCF

For the Diagnostics & Research subindustry, SMO Clinplus Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SMO Clinplus Co's EV-to-FCF Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, SMO Clinplus Co's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where SMO Clinplus Co's EV-to-FCF falls into.



SMO Clinplus Co EV-to-FCF Calculation

SMO Clinplus Co's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=1553.451/76.408
=20.33

SMO Clinplus Co's current Enterprise Value is ¥1,553.5 Mil.
SMO Clinplus Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥76.4 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


SMO Clinplus Co  (SZSE:301257) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

SMO Clinplus Co's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=29.32/1.684
=17.41

SMO Clinplus Co's share price for today is ¥29.32.
SMO Clinplus Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥1.684.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


SMO Clinplus Co EV-to-FCF Related Terms

Thank you for viewing the detailed overview of SMO Clinplus Co's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


SMO Clinplus Co (SZSE:301257) Business Description

Traded in Other Exchanges
N/A
Address
No. 105 Sinan Road, Room 108, Building 1, Huangpu District, Shanghai, CHN, 200001
SMO Clinplus Co Ltd is engaged in providing SMO services to domestic and foreign pharmaceutical companies, medical device companies and clinical research and development of some health-related products. The services provided include Preliminary model establishment, Preliminary plan preparation, Initiation of clinical trial sites, On-site implementation, and Comprehensive project management.
Executives
Lai Chun Bao Director
Ma Lin Director

SMO Clinplus Co (SZSE:301257) Headlines

No Headlines